-
-
-
-
-
-
-
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Ad
-
-
-
-
-
-
-
Merck Animal Health to Acquire TARGAN
-
-
-
-
-
-
-
Merck Animal Health Selects Salesforce’s Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for Employees
-
-
-
-
-
-
-
Merck clears HSR waiting period for $53 per share Terns acquisition
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Merck (MRK)
-
-
-
-
-
-
-
Enliven Therapeutics stock surges 28% on Merck-Terns deal
-
-
-
-
-
-
-
Merck (MRK) PT Raised to $109 at Morgan Stanley
-
1,169,665 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

